Log In
BCIQ
Print this Print this
 

huDS6-DM4 (SAR566658)

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionHumanized mAb against carbonic anhydrase VI (CAVI) linked to ImmunoGen's DM4 cytotoxic agent
Molecular Target Carbonic anhydrase VI (CAVI)
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat advanced ovarian and other solid tumors; Treat advanced solid tumors; Treat refractory CAVI-positive solid tumors
Regulatory Designation
PartnerImmunoGen Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today